This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an obesity medication that works differently than its popular Wegovy.
FRIDAY, June 13, 2025 — A person’s microbiome – the bacteria naturally living in the mouth and gut – might contribute to Parkinson’s disease, a new study says.Specific changes in these bacteria are associated with cognitive decline in Parkinson’s, r.
Clinical research generates vast amounts of diverse data from laboratory tests, patients, medical equipment, and outside sources. By organising and analysing this information, researchers can extract actionable insights that improve patient outcomes, data accuracy, drug efficacy and speed up trials.
FRIDAY, June 13, 2025 — CT scans might be able to prevent more colon cancers than stool DNA tests, a new study says.CT colonography performed every three to five years could ward off more cases of cancer than DNA testing of stool to look for e.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
"The Hiring Spree You Didn't See Coming: 3 Industries Where Clinical Trials Are Fueling a Surge in Legal Support As the pharmaceutical industry continues to navigate a complex landscape of patent expirations and emerging treatments, a new trend is emerging: companies are hiring lawyers at an unprecedented rate to protect their interests in the face of clinical trial data.
FRIDAY, June 13, 2025 — More than 460 laid-off employees at the U.S. Centers for Disease Control and Prevention (CDC) are being rehired, officials said June 11.The reinstatement notices went out this week, according to the U.S. Department of Health.
Johnson & Johnson’s Dual-Targeting CAR T-Cell Therapy Shows Encouraging First Clinical Results in Large B-Cell Lymphoma Johnson & Johnson recently presented promising first-in-human data from its ongoing Phase 1b study evaluating JNJ-90014496 (JNJ-4496) — an investigational, dual-targeting, autologous chimeric antigen receptor (CAR) T-cell therapy — in patients with relapsed or refractory large B-cell lymphoma (R/R LBCL) who have not previously received a CAR T-cell therapy.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Johnson & Johnson’s Dual-Targeting CAR T-Cell Therapy Shows Encouraging First Clinical Results in Large B-Cell Lymphoma Johnson & Johnson recently presented promising first-in-human data from its ongoing Phase 1b study evaluating JNJ-90014496 (JNJ-4496) — an investigational, dual-targeting, autologous chimeric antigen receptor (CAR) T-cell therapy — in patients with relapsed or refractory large B-cell lymphoma (R/R LBCL) who have not previously received a CAR T-cell therapy.
FRIDAY, June 13, 2025 — Brain changes in sleepless teens could make them more likely to be impulsive and aggressive, a new study says.Teenagers with less sleep had lower connectivity between the parts of the brain that play a critical role in d.
Mitsubishi Research Institute and Astellas Forge Collaborative Initiative to Support Japanese Drug Discovery Startups and Boost Global Innovation Mitsubishi Research Institute, Inc. (MRI) and Astellas Pharma Inc. (Astellas) today announced a significant new collaboration aimed at strengthening Japan’s role as a global hub for innovative drug discovery and fostering the growth of its biotechnology startups.
FRIDAY, June 13, 2025 — Kids exposed to PFAS “forever chemicals” before birth have an increased risk of high blood pressure in childhood, particularly during their teen years, a new study says.Teenage boys had a 17% higher risk of increased risk of.
Today’s guest post comes from Sean Wagner, VP of Client Partnerships and Carolyn Zele, Advisor, Solution Consulting at MMIT. Sean and Carolyn argue that planning for a successful drug launch must begin early—often well before Phase III. In this article, they present a six-step framework to help manufacturers align clinical development with payer expectations, patient needs, and real-world access dynamics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FRIDAY, June 13, 2025 -- Tooth disorders accounted for an annual average of 1,944,000 emergency department visits during 2020 to 2022, according to a June data brief published by the National Center for Health Statistics.Susan M. Schappert and.
Elanco’s Zenrelia (ilunocitinib) Wins Positive CVMP Opinion, Paving the Way for EU Approval and Market Release Elanco Animal Health Incorporated (NYSE: ELAN) today announces a significant milestone in its ongoing expansion into veterinary care: the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has issued a positive opinion for Zenrelia™ (ilunocitinib).
FRIDAY, June 13, 2025 — Traumatic childhood events can increase a woman’s risk of endometriosis later in life, a new study says.Women’s endometriosis risk increased 20% if they had experienced childhood ordeals such as violence, sexual abuse, a deat.
Caught between negotiations with Washington over tariffs and Beijing's upgrading of export controls, Europe finds itself in a defensive and reactive position. The task at hand for European and British decisionmakers is once again to define their own interests and chart a path to achieve them.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
FRIDAY, June 13, 2025 — Sleep apnea could be more common in female college athletes than previously thought, a new study says.Mild sleep apnea was observed in a quarter of a group of 68 female athletes, according to findings presented Thursday at a.
Single Sign-On (SSO) is a crucial part of modern web applications, enabling users to authenticate once and access multiple systems securely. If your organization uses Salesforce as an Identity Provider (IdP) and Drupal as a Service Provider (SP) , you can establish a secure SSO connection using the SAML protocol. In this blog, we’ll walk through how to integrate Drupal with Salesforce for SSO using the SAML Authentication module.
As biomedical research evolves, the responsibility to align scientific progress with ethical practice evolves too. Dr. Liz Nunamaker, Executive Director of Global Animal Welfare at Charles River , is leading efforts to embed welfare, integrity and the 3Rs – replacement, reduction and refinement – into the heart of drug discovery and development. In this interview, she discusses her career path, the challenges of global standards and the practical impact of applying the 3Rs across research settin
FRIDAY, June 13, 2025 — Alcohol-related liver disease deaths are increasing — and they’re rising faster in some groups, including women, young adults and Indigenous people, new research shows.Between 2018 and 2022, deaths from alcohol-associated liv.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
FDA Approves KEYTRUDA® (Pembrolizumab) for Perioperative Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma Merck known as MSD outside the United States and Canada, recently announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), its flagship anti-PD-1 therapy, for the treatment of adult patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1 (Combined Positive Score
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed cashed in on a stock surge and Third Harmonic kicked off a drug auction.
Amgen and Barry Sanders Raise Awareness About “Bad Cholesterol” in Documentary Highlighting Cardiovascular Disease Crisis in America Amgen today announced the launch of The Making of a Heart Attack , a powerful documentary that aims to illuminate the growing cardiovascular disease crisis in the United States — a condition that strikes someone nearly every 40 seconds with a heart attack or stroke.
FRIDAY, June 13, 2025 — Ananda Lewis, a former MTV host and TV personality, is dead at 52.Her friend Lakshmi Emory shared the news in a June 11 Facebook post. “She’s free, and in His heavenly arms,” Emory wrote, alongside a black-and-white photo of.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
mRNA Technology Transfer Programme Moves Into Phase 2.0, Boosting Sustainable Local Vaccine Manufacturing and Global Health Security In parallel with the G20 Health Working Group meeting, global health leaders and stakeholders are gathering in Johannesburg, South Africa, to accelerate the implementation of a new phase of the mRNA Technology Transfer Programme — a groundbreaking initiative designed to enable low- and middle-income countries (LMICs) to produce their own vaccines and biologics, str
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s been significantly impacted by the recent changes in FDA and HHS leadership.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content